Reportlinker Adds Industry Dynamics: 2010 Guide to the Asia-Pacific Life Sciences Industry
NEW YORK, Dec. 9, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Industry Dynamics: 2010 Guide to the Asia-Pacific Life Sciences Industry
Introduction
Pharmaceutical companies are expanding into the Asia-Pacific region to increase their market share and reduce costs. The life sciences industry is difficult enough for technology vendors to enter, but add to it the complexity of emerging markets, and the process can be downright overwhelming. Ovum provides an Introduction to the life sciences in APAC in order for vendors to penetrate the market.
Features and benefits
Offers an overview of the pharmaceutical and biotechnology sectors in Australia, China, India, and Japan
Discusses key areas where there is greatest need for technology in the APAC life sciences industry
Provides go-to-market strategies to help vendors enter the APAC pharma and biotech markets and realize successful
Highlights
Before attempting to penetrate the APAC pharma market, it is important to understand the complexity of the global life sciences industry. Once vendors understand the industry as a whole, they will better comprehend the dynamics of the APAC markets and how the developed and emerging pharma industries fit into their customers' global strategies.
The Asia-Pacific life sciences industry varies greatly, comprised of both developed and emerging markets. It is also home to small, emerging biotech companies with up to ten employees as well as Big Pharma with thousands of employees. As wide as the spectrum is for size and type of life sciences company, so is the need for IT solutions.
The emerging markets have seen tremendous growth, and this trend will likely continue, but not without the help of key IT solutions. The APAC pharma and biotech sectors are much more open to the use of IT that their Western counterparts, but it is still important for technology vendors to understand where and how to best realize success.
Your key questions answered
Understand the pharmaceutical and biotechnology product lifecycle and business processes
Identify emerging areas of concern for pharmaceutical and biotechnology companies, particularly in Australia, China, India and Japan
Gain insight into what solutions and services will appeal most to APAC life sciences companies
TABLE OF CONTENTS
SUMMARY 1
Catalyst 1
Ovum view 2
Key messages 3
Understanding the Pharma Process 8
About the industry 8
The drug discovery and development process is long and expensive 9
The biggest challenge facing the pharma industry is the successful navigation of the 2011 patent cliff 16
The APAC Life Sciences Market 19
Overview of APAC markets 19
Australia's pharmaceutical market 20
China's pharmaceutical market 21
India's pharmaceutical market 23
Japan's pharmaceutical market 25
Slowing growth in major developed markets drives pharma M&A in APAC 26
Trends within countries based on the process areas 27
Opportunities for Technology Vendors 32
How best to capitalize 32
The pharma product lifecycle plays a crucial role in IT strategy 32
IT engagement with pharma comes with its own set of dynamics 42
With no two life sciences markets exactly the same, neither is their IT investment 48
Recommendations for Technology Vendors 53
The right solutions for the right processes 53
Position technology along the pharma lifecycle 53
Know the pharma company's product pipeline and drug portfolio 54
Route to market will be a critical success factor 54
Keep in mind that IT budget allocation does not equal priority 55
Focus on IT solutions that enable the shift towards biotech research 56
APPENDIX 57
Definitions 57
Further reading 58
Methodology 59
Ovum authors 61
Datamonitor author 61
Ovum Consulting 62
Disclaimer 62
TABLE OF
FIGURES
Figure 1: The drug discovery and development lifecycle 9
Figure 2: The drug discovery and pre-clinical research processes 10
Figure 3: The clinical trials process 11
Figure 4: SCOR: Capturing the pharma manufacturing process 13
Figure 5: Stakeholders involved in pharma sales and marketing 14
Figure 6: The sales and marketing process through shelf-time 16
Figure 7: Loss in sales due to generic erosion from brands expiring between 2010 and 2014 17
Figure 8: Heat map of discovery and pre-clinical research activity in APAC 28
Figure 9: Heat map of clinical trial activity in APAC 29
Figure 10: Heat map of manufacturing activity in APAC 30
Figure 11: Heat map of sales and marketing activity in APAC 31
Figure 12: The pharma business processes and associated IT solutions 33
Figure 13: Heat map of research IT adoption in APAC over five years 35
Figure 14: Heat map of clinical research IT adoption in APAC over five years 36
Figure 15: Heat map of manufacturing IT adoption in APAC over five years 38
Figure 16: Heat map of sales and marketing IT adoption in APAC over five years 41
Figure 17: Percentage of IT budget allocated to various technology solutions 42
Figure 18: Pharma IT budget allocations by technology category 44
Figure 19: Cloud computing adoption plans in pharma companies 46
Figure 20: Influence of C-level executives on IT investment 47
Figure 21: Australia's IT spending by life sciences sector, 2009-2015 49
Figure 22: China's IT spending by life sciences sector, 2009-2015 50
Figure 23: India's IT spending by life sciences sector, 2009-2015 51
Figure 24: Japan's IT spending by life sciences sector, 2009-2015 52
Figure 25: Priority of technology solution for IT budget allocation 55
TABLE OF
TABLES
Table 1: Pharmaceutical and biotechnology industry sub-segments 8
Table 2: Key population, healthcare expenditure and pharmaceutical and biotechnology market indicators for APAC 19
Table 3: Sales growth for the leading pharmaceutical and biotechnology companies in APAC, 2005–9 20
To order this report:
Healthcare Industry: Industry Dynamics: 2010 Guide to the Asia-Pacific Life Sciences Industry
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT: |
|
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article